KeywordsQUALITY OF LIFE
Local subject classificationBOWEL DYSFUNCTION
MetadataShow full item record
CitationO'Brien, Tony. The Attractiveness of Opposites: Agonists and Antagonists. 2015: J Pain Palliat Care Pharmacother
JournalJournal of pain & palliative care pharmacotherapy
AbstractABSTRACT Opioid-induced bowel dysfunction, of which constipation is the most common aspect, is a major limiting factor in the use of opioids for pain management. The availability of an oral, long-acting formulation of oxycodone and naloxone represents a highly significant development in pain management. The combination of an opioid analgesic with an opioid antagonist offers reliable pain control with a significant reduction in the burden of opioid-induced constipation. This report is adapted from paineurope 2014; Issue 3, ©Haymarket Medical Publications Ltd, and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, LTD and is distributed free of charge to healthcare professionals in Europe. Archival issues can be accessed via the website: http://www.paineurope.com at which European health professionals can register online to receive copies of the quarterly publication.